Patent issued for nanotechnology bone biomaterial

NewsGuard 100/100 Score

Competitive Technologies announced today that patent number 6,808,561 has been issued by the US Patent Office for Dr. Brian R. Genge's nanotechnology bone biomaterial developed at the University of South Carolina (USC).

CTT has an exclusive agreement with the University of South Carolina Research Foundation to license and commercialize the nanotechnology, an injectible calcium phosphate-based biomaterial. Dr. Genge is a research professor in the Department of Chemistry and Biochemistry at USC.

"The granting of this patent recognizes the unique qualities of Dr. Genge's innovative nanoparticle biomaterial technology," said Suzanne N. B. Alent, CTT's VP Marketing and Business Development. "CTT has an agreement with a major dental products company to research the manufacture and use of this nanotechnology for dental applications. We will continue to aggressively market this superior technology for all aspects of its capabilities."

In addition to its use in the dental field, the patented nanotechnology can also be applied to a variety of human orthopedic procedures, especially related to the spine and craniofacial reconstruction, as well as veterinary uses. The bone biomaterial technology is an easily flowable, moldable paste that conforms to and interdigitates with the host bone. It rapidly hardens itself in vivo, forming a solid bone-like structure capable of stabilizing fractured bone within 15 minutes and supports the growth of cartilage and bone cells. The technology has superior compressive strength making it suitable for weight and non-weight bearing bones, and is both machinable and drillable.

John B. Nano, CTT's President and CEO said, "CTT is proud to continue its successful relationship with USC and Dr. Genge. We are building and renewing our strong, global alliances with universities, companies and individual inventors. Bone biomaterial is just one of the exciting technologies in CTT's innovative portfolio. We are actively marketing and commercializing several technologies, including homocysteine assays, video compression and decoding technology, sexual dysfunction treatment, sunless tanning application, silicon carbide wafer testing, encryption technology, EZSpeech(TM) language-mastering software, an anti-cancer compound and the Therapik(R) device."

Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists regenerate fully functional urinary bladder tissue using a non-human primate model